Quest Diagnostics (DGX) Depreciation & Amortization (CF) (2009 - 2026)

Quest Diagnostics has disclosed Depreciation & Amortization (CF) across 18 years of filings, most recently posting $146.0 million for Q2 2026.

• In Q2 2026, Depreciation & Amortization (CF) rose 2.1% year-over-year to $146.0 million; the TTM figure through Jun 2026 stood at $580.0 million (up 6.81% YoY), while the FY2025 annual figure was $570.0 million, up 15.62% from the prior year.
• Depreciation & Amortization (CF) came in at $146.0 million for Q2 2026 at Quest Diagnostics, down from $147.0 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $147.0 million in Q1 2026 to a low of $106.0 million in Q1 2022.
• Average Depreciation & Amortization (CF) over 5 years is $124.0 million, with a median of $116.5 million recorded in 2022.
• Year-over-year, Depreciation & Amortization (CF) decreased 6.03% in 2023 and grew 23.85% in 2024.
• Over 5 years, Depreciation & Amortization (CF) stood at $116.0 million in 2022, then retreated by 6.03% to $109.0 million in 2023, then increased by 23.85% to $135.0 million in 2024, then grew by 7.41% to $145.0 million in 2025, then rose by 0.69% to $146.0 million in 2026.
• Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $146.0 million in Q2 2026, $147.0 million in Q1 2026, and $145.0 million in Q4 2025.